As histone variants come into the limelight of epigenetic regulation in cancer [13], this review discusses different aspects of one of the most structurally and functionally controversial variants, H2A.Z [9], and its involvement in prostate cancer. This evidence concerns the gene H2AZ1 and prostate carcinoma.